2025 Q3 -tulosraportti
75 päivää sitten23 min
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
4 738
Myynti
Määrä
9 898
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 11 222 | - | - | ||
| 9 342 | - | - | ||
| 22 236 | - | - | ||
| 104 | - | - | ||
| 100 | - | - |
Ylin
0,949VWAP
Alin
0,948VaihtoMäärä
0,1 99 302
VWAP
Ylin
0,949Alin
0,948VaihtoMäärä
0,1 99 302
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 99 709 | 99 709 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 99 709 | 99 709 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 20.3. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 15.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 20.3.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·49 min sittenØkonomisk Ugebrev had an article about, among others, BioPorto 14 days ago. The article is called "Good Danish Life Science stocks for 2026".·21 min sittenØU calls it a "joker"? That must be false labeling to call it a "good ...stock" in that context. It's damn unprofessional written by ØU.
·3 päivää sittenSo, are we looking towards “EndGame” for this stock here? Have been in it for many years hoping for a sudden resolution. But it never comes.... What do people think?- ·28.1.Why the rush to sell at this low price?
·3 päivää sittenSo incredibly little is happening regarding sales, so another rights issue seems unavoidable. Such a one must be prepared well in advance, and whether it comes in 2. or 3 quarter is essentially irrelevant. As I recall the numbers, and I'm too lazy to check, I rather thought they would be lucky if the money would last through the summer. But again, whether the rights issue comes a quarter earlier or later doesn't really matter. I have recently become more pessimistic regarding BP because I think a picture is emerging that there is absolutely not the demand for ngal that many had hoped and expected.
·3 päivää sittenIt's probably because it has taken far too long to develop it, but red figures on the price chart are not very exciting to look at. Now I have had them for 7 quarters, and it has been a long downturn, and I only give them 3 more months to improve a bit, as I will otherwise sell them despite a large loss. - ·28.1.First of all. CB has at no point mentioned that Bioporto has plans to market itself in India. I'm just curious. Now that the EU and India have reached a trade agreement, it occurred to me that it was stated that now that the NGAL test has been approved by the FDA, this approval would also apply in other countries, because they recognize FDA's approval method. I believe I recall that India is one of these countries that approves FDA, the reason being that FDA has the toughest approval procedure in the world. I can't find anything on it myself, so the question is, is it correctly remembered that India approves the FDA label?·28.1.As you write, this approval is before EU and India have signed a trade agreement. This means that from now on, there will be no extra customs duties on medical products and equipment anymore. When the NGAL test was approved back then, there were sky-high customs duties on products from the EU, so I guess that's why PME thought it was not feasible to sell the NGAL test in India at this time. Now that the EU has a trade agreement with India, the Indian embassy in Denmark has stated that they will be helpful in establishing networks in India because it is very difficult to navigate in India, according to the embassy. Now that there is an approval, I very much hope that CB will enter the Indian market. India is very keen to buy medical equipment from EU countries according to an analyst from Tv2 news https://jyllands-posten.dk/erhverv/ECE18958146/eu-og-indien-indgaar-handelsaftale-og-saenker-told-paa-mad-og-alkohol/
- ·27.1.Now it's just a matter of hoping that CB looks towards India, because today the EU has signed a trade agreement with India. According to an analyst from Radioavisen, who stated, informed that Denmark will benefit from this agreement by medical manufacturers being able to sell medical equipment and medicine to India, which they are very keen to buy. India will initially benefit from the agreement because they want to sell clothes to Denmark, which also wants to buy clothes from India. https://www.kristeligt-dagblad.dk/udland/indiens-premierminister-melder-om-stor-handelsaftale-med-eu
·20 t sittenIt's completely ridiculous to believe India can save BioPorto :D :D :D·51 min sittenShouldn't it say "realistic" in the 3rd line, with a "not" in front.... BP should not invest one krone more than necessary and capital is so scarce that it is a fight for survival. That fight will be lost if BP suddenly has to "conquer" a new market where BP sells nothing.... the fight is already being lost, now that it's about 1.5 years after the big approval and still nothing has been delivered in terms of performance that confirms a potential. It could very soon be over if the results don't come... be careful out there.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
75 päivää sitten23 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·49 min sittenØkonomisk Ugebrev had an article about, among others, BioPorto 14 days ago. The article is called "Good Danish Life Science stocks for 2026".·21 min sittenØU calls it a "joker"? That must be false labeling to call it a "good ...stock" in that context. It's damn unprofessional written by ØU.
- ·3 päivää sittenSo, are we looking towards “EndGame” for this stock here? Have been in it for many years hoping for a sudden resolution. But it never comes.... What do people think?
- ·28.1.Why the rush to sell at this low price?·3 päivää sittenSo incredibly little is happening regarding sales, so another rights issue seems unavoidable. Such a one must be prepared well in advance, and whether it comes in 2. or 3 quarter is essentially irrelevant. As I recall the numbers, and I'm too lazy to check, I rather thought they would be lucky if the money would last through the summer. But again, whether the rights issue comes a quarter earlier or later doesn't really matter. I have recently become more pessimistic regarding BP because I think a picture is emerging that there is absolutely not the demand for ngal that many had hoped and expected.·3 päivää sittenIt's probably because it has taken far too long to develop it, but red figures on the price chart are not very exciting to look at. Now I have had them for 7 quarters, and it has been a long downturn, and I only give them 3 more months to improve a bit, as I will otherwise sell them despite a large loss.
- ·28.1.First of all. CB has at no point mentioned that Bioporto has plans to market itself in India. I'm just curious. Now that the EU and India have reached a trade agreement, it occurred to me that it was stated that now that the NGAL test has been approved by the FDA, this approval would also apply in other countries, because they recognize FDA's approval method. I believe I recall that India is one of these countries that approves FDA, the reason being that FDA has the toughest approval procedure in the world. I can't find anything on it myself, so the question is, is it correctly remembered that India approves the FDA label?·28.1.As you write, this approval is before EU and India have signed a trade agreement. This means that from now on, there will be no extra customs duties on medical products and equipment anymore. When the NGAL test was approved back then, there were sky-high customs duties on products from the EU, so I guess that's why PME thought it was not feasible to sell the NGAL test in India at this time. Now that the EU has a trade agreement with India, the Indian embassy in Denmark has stated that they will be helpful in establishing networks in India because it is very difficult to navigate in India, according to the embassy. Now that there is an approval, I very much hope that CB will enter the Indian market. India is very keen to buy medical equipment from EU countries according to an analyst from Tv2 news https://jyllands-posten.dk/erhverv/ECE18958146/eu-og-indien-indgaar-handelsaftale-og-saenker-told-paa-mad-og-alkohol/
- ·27.1.Now it's just a matter of hoping that CB looks towards India, because today the EU has signed a trade agreement with India. According to an analyst from Radioavisen, who stated, informed that Denmark will benefit from this agreement by medical manufacturers being able to sell medical equipment and medicine to India, which they are very keen to buy. India will initially benefit from the agreement because they want to sell clothes to Denmark, which also wants to buy clothes from India. https://www.kristeligt-dagblad.dk/udland/indiens-premierminister-melder-om-stor-handelsaftale-med-eu·20 t sittenIt's completely ridiculous to believe India can save BioPorto :D :D :D·51 min sittenShouldn't it say "realistic" in the 3rd line, with a "not" in front.... BP should not invest one krone more than necessary and capital is so scarce that it is a fight for survival. That fight will be lost if BP suddenly has to "conquer" a new market where BP sells nothing.... the fight is already being lost, now that it's about 1.5 years after the big approval and still nothing has been delivered in terms of performance that confirms a potential. It could very soon be over if the results don't come... be careful out there.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
4 738
Myynti
Määrä
9 898
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 11 222 | - | - | ||
| 9 342 | - | - | ||
| 22 236 | - | - | ||
| 104 | - | - | ||
| 100 | - | - |
Ylin
0,949VWAP
Alin
0,948VaihtoMäärä
0,1 99 302
VWAP
Ylin
0,949Alin
0,948VaihtoMäärä
0,1 99 302
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 99 709 | 99 709 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 99 709 | 99 709 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 20.3. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 15.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 20.3.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
2025 Q3 -tulosraportti
75 päivää sitten23 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 20.3. |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 19.11.2025 | |
| 2025 Q2 -tulosraportti | 15.8.2025 | |
| 2025 Q1 -tulosraportti | 8.5.2025 | |
| 2024 Q4 -tulosraportti | 20.3.2025 | |
| 2024 Q3 -tulosraportti | 14.11.2024 |
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·49 min sittenØkonomisk Ugebrev had an article about, among others, BioPorto 14 days ago. The article is called "Good Danish Life Science stocks for 2026".·21 min sittenØU calls it a "joker"? That must be false labeling to call it a "good ...stock" in that context. It's damn unprofessional written by ØU.
- ·3 päivää sittenSo, are we looking towards “EndGame” for this stock here? Have been in it for many years hoping for a sudden resolution. But it never comes.... What do people think?
- ·28.1.Why the rush to sell at this low price?·3 päivää sittenSo incredibly little is happening regarding sales, so another rights issue seems unavoidable. Such a one must be prepared well in advance, and whether it comes in 2. or 3 quarter is essentially irrelevant. As I recall the numbers, and I'm too lazy to check, I rather thought they would be lucky if the money would last through the summer. But again, whether the rights issue comes a quarter earlier or later doesn't really matter. I have recently become more pessimistic regarding BP because I think a picture is emerging that there is absolutely not the demand for ngal that many had hoped and expected.·3 päivää sittenIt's probably because it has taken far too long to develop it, but red figures on the price chart are not very exciting to look at. Now I have had them for 7 quarters, and it has been a long downturn, and I only give them 3 more months to improve a bit, as I will otherwise sell them despite a large loss.
- ·28.1.First of all. CB has at no point mentioned that Bioporto has plans to market itself in India. I'm just curious. Now that the EU and India have reached a trade agreement, it occurred to me that it was stated that now that the NGAL test has been approved by the FDA, this approval would also apply in other countries, because they recognize FDA's approval method. I believe I recall that India is one of these countries that approves FDA, the reason being that FDA has the toughest approval procedure in the world. I can't find anything on it myself, so the question is, is it correctly remembered that India approves the FDA label?·28.1.As you write, this approval is before EU and India have signed a trade agreement. This means that from now on, there will be no extra customs duties on medical products and equipment anymore. When the NGAL test was approved back then, there were sky-high customs duties on products from the EU, so I guess that's why PME thought it was not feasible to sell the NGAL test in India at this time. Now that the EU has a trade agreement with India, the Indian embassy in Denmark has stated that they will be helpful in establishing networks in India because it is very difficult to navigate in India, according to the embassy. Now that there is an approval, I very much hope that CB will enter the Indian market. India is very keen to buy medical equipment from EU countries according to an analyst from Tv2 news https://jyllands-posten.dk/erhverv/ECE18958146/eu-og-indien-indgaar-handelsaftale-og-saenker-told-paa-mad-og-alkohol/
- ·27.1.Now it's just a matter of hoping that CB looks towards India, because today the EU has signed a trade agreement with India. According to an analyst from Radioavisen, who stated, informed that Denmark will benefit from this agreement by medical manufacturers being able to sell medical equipment and medicine to India, which they are very keen to buy. India will initially benefit from the agreement because they want to sell clothes to Denmark, which also wants to buy clothes from India. https://www.kristeligt-dagblad.dk/udland/indiens-premierminister-melder-om-stor-handelsaftale-med-eu·20 t sittenIt's completely ridiculous to believe India can save BioPorto :D :D :D·51 min sittenShouldn't it say "realistic" in the 3rd line, with a "not" in front.... BP should not invest one krone more than necessary and capital is so scarce that it is a fight for survival. That fight will be lost if BP suddenly has to "conquer" a new market where BP sells nothing.... the fight is already being lost, now that it's about 1.5 years after the big approval and still nothing has been delivered in terms of performance that confirms a potential. It could very soon be over if the results don't come... be careful out there.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
4 738
Myynti
Määrä
9 898
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 11 222 | - | - | ||
| 9 342 | - | - | ||
| 22 236 | - | - | ||
| 104 | - | - | ||
| 100 | - | - |
Ylin
0,949VWAP
Alin
0,948VaihtoMäärä
0,1 99 302
VWAP
Ylin
0,949Alin
0,948VaihtoMäärä
0,1 99 302
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 99 709 | 99 709 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 99 709 | 99 709 | 0 | 0 |